pLX307 Luciferase Citations (3)

Originally described in: MCL1 and DEDD promote urothelial carcinoma progression.
Hong AL, Guerriero JL, Doshi MB, Kynnap BD, Kim WJ, Schinzel AC, Modiste R, Schlauch AJ, Adam RM, Kwiatkowski DJ, Beroukhim R, Letai A, Rosenberg JE, Hahn WC Mol Cancer Res. 2019 Feb 18. pii: 1541-7786.MCR-18-0963. doi: 10.1158/1541-7786.MCR-18-0963. PubMed Journal

---

Articles Citing pLX307 Luciferase

Articles
cDNA-detector: detection and removal of cDNA contamination in DNA sequencing libraries. Qi M, Nayar U, Ludwig LS, Wagle N, Rheinbay E. BMC Bioinformatics. 2021 Dec 24;22(1):611. doi: 10.1186/s12859-021-04529-2. PubMed
Induction of Synthetic Lethality by Activation of Mitochondrial ClpP and Inhibition of HDAC1/2 in Glioblastoma. Nguyen TTT, Shang E, Schiffgens S, Torrini C, Shu C, Akman HO, Prabhu VV, Allen JE, Westhoff MA, Karpel-Massler G, Siegelin MD. Clin Cancer Res. 2022 May 2;28(9):1881-1895. doi: 10.1158/1078-0432.CCR-21-2857. PubMed
Genomic screening reveals ubiquitin-like modifier activating enzyme 1 as a potent and druggable target in c-MYC-high triple negative breast cancer models. Jacob S, Turner TH, Cai J, Floros KV, Yu AK, Coon CM, Khatri R, Alzubi MA, Jakubik CT, Bouck YM, Puchalapalli M, Shende M, Dozmorov MG, Boikos SA, Hu B, Harrell JC, Benes CH, Koblinski JE, Costa C, Faber AC. PNAS Nexus. 2022 Oct 11;1(5):pgac232. doi: 10.1093/pnasnexus/pgac232. eCollection 2022 Nov. PubMed

If you have published an article using this material, please email us at to have your article added to this page.